AbbVie Rips 'Unsound' FDA Stand On Biosimilar Labels
The U.S. Food and Drug Administration has violated federal law in several respects by allowing biosimilars to use labeling that's virtually identical to the labeling used by their brand-name counterparts, AbbVie...To view the full article, register now.
Already a subscriber? Click here to view full article